A mouse model offers novel insights into the myopathy and tendinopathy often associated with pseudoachondroplasia and multiple epiphyseal dysplasia

Human Molecular Genetics

Volumn 19, Issue 1, 2009, Pages 52-64

  Piróg, Katarzyna A ^a   Jaka, Oihane ^a,c   Katakura, Yoshihisa ^b   Meadows, Roger S ^a   Kadler, Karl E ^a   Boot Handford, Raymond P ^a   Briggs, Michael D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HOSPITAL DONOSTIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN FIBRIL; CARTILAGE MATRIX PROTEIN; FIBRILLAR COLLAGEN; GLYCOPROTEIN; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DYSPLASIA; CELL NUCLEUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EPIPHYSIS DISEASE; GENE MUTATION; LIGAMENT DISEASE; MOUSE; MUSCLE WEAKNESS; MYOPATHY; NONHUMAN; PERIMYSIUM; PHENOTYPE; PRIORITY JOURNAL; PSEUDOCHONDRODYSPLASIA; SKELETAL MUSCLE; TENDINITIS; ACHILLES TENDON; ANIMAL; APOPTOSIS; BIOMECHANICS; CHONDRODYSPLASIA; DISEASE MODEL; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; LIGAMENT; METABOLISM; MOUSE MUTANT; PATHOLOGY; ULTRASTRUCTURE;

MUS;

ACHILLES TENDON; ANIMALS; APOPTOSIS; BIOMECHANICS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRILLAR COLLAGENS; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; LIGAMENTS; MICE; MICE, MUTANT STRAINS; MUSCLE FIBERS, SKELETAL; MUSCLE WEAKNESS; OSTEOCHONDRODYSPLASIAS; TENDINOPATHY;

EID: 77649322497     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp466     Document Type: Article

References (66)

1. Rimoin, D.L., Rasmussen, I.M., Briggs, M.D., Roughley, P.J., Gruber, H.E., Warman, M.L., Olsen, B.R., Hsia, Y.E., Yuen, J., Reinker, K. et al. (1994) A large family with features of pseudoachondroplasia and multiple epiphyseal dysplasia: exclusion of seven candidate gene loci that encode proteins of the cartilage extracellular matrix. Hum. Genet., 93, 236-242.
2. McKeand, J., Rotta, J. and Hecht, J.T. (1996) Natural history study of pseudoachondroplasia. Am. J. Med. Genet., 63, 406-410.
3. Spranger, J. (1985) Pattern recognition in bone dysplasias. Prog. Clin. Biol. Res., 200, 315-342.
4. Briggs, M.D., Hoffman, S.M., King, L.M., Olsen, A.S., Mohrenweiser, H., Leroy, J.G., Mortier, G.R., Rimoin, D.L., Lachman, R.S., Gaines, E.S. et al. (1995) Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in cartilage oligomeric matrix protein gene. Nat. Genet., 10, 330-336.
5. Hecht, J.T., Nelson, L.D., Crowder, E., Wang, Y., Elder, F.F., Harrison, W.R., Francomano, C.A., Prange, C.K., Lennon, G.G., Deere, M. and Lawler, J. (1995) Mutations in exons 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat. Genet., 10, 325-329.
6. Oldberg, A., Antonsson, P., Lindblom, K. and Heinegard, D. (1992) COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J. Biol. Chem., 267, 22346-22350.
7. Maddox, B.K., Mokashi, A., Keene, D.R. and Bachinger, H.P. (2000) A cartilage oligomeric matrix protein mutation associated with pseudoachondroplasia changes the structural and functional properties of the type 3 domain. J. Biol. Chem., 275, 11412-11417.
8. Cesare, P.E.D., Carlos, C.S., Stollerman, E.S., Chen, F.S., Leslie, M. and Perris, R. (1997) Expression of cartilage oligomeric matrix protein by human synovium. FEBS Lett., 412, 249-252.
9. Fang, C., Carlson, C.S., Leslie, M.P., Tulli, H., Stolerman, E., Perris, R., Ni, L. and Di Cesare, P.E. (2000) Molecular cloning, sequencing, and Human Molecular Genetics, 2010, Vol. 19, No. 1 63 tissue and developmental expression of mouse cartilage oligomeric protein (COMP). J. Orth. Res., 18, 593-603.
10. Budde, B., Blumbach, K., Ylostalo, J., Zaucke, F., Ehlen, H.W., Wagener, R., Ala-Kokko, L., Paulsson, M., Bruckner, P. and Grassel, S. (2005) Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX. Mol. Cell Biol., 25, 10465-10478.
11. Thur, J., Rosenberg, K., Nitsche, D.P., Pihlajamaa, T., Ala-Kokko, L., Heinegard, D., Paulsson, M. and Maurer, P. (2001) Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J. Biol. Chem., 276, 6083-6092.
12. Hecht, J.T., Hayes, E., Snuggs, M., Decker, G., Montufar-Solis, D., Doege, K., Mwalle, F., Poole, R., Stevens, J. and Duke, P.J. (2001) Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes. Matrix Biol., 20, 251-262.
13. Di Cesare, P.E., Chen, F.S., Moergelin, M., Carlson, C.S., Leslie, M.P., Perris, R. and Fang, C. (2002) Matrix-matrix interaction of cartilage oligomeric matrix protein and fibronectin. Matrix Biol., 21, 461-470.
14. Mann, H.H., Ozbek, S., Engel, J., Paulsson, M. and Wagener, R. (2004) Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J. Biol. Chem., 279, 25294-25298.
15. Holden, P., Meadows, R.S., Chapman, K.L., Grant, M.E., Kadler, K.E. and Briggs, M.D. (2001) Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J. Biol. Chem., 276, 6046-6055.
16. Halasz, K., Kassner, A., Morgelin, M. and Heinegard, D. (2007) COMP acts as a catalyst in collagen fibrillogenesis. J. Biol. Chem., 282, 31166-31173.
17. Kennedy, J., Jackson, G.C., Barker, F.S., Nundlall, S., Bella, J., Wright, M.J., Mortier, G.R., Neas, K., Thompson, E., Elles, R. and Briggs, M.D. (2005) Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia-multiple epiphyseal dysplasia disease group. Hum. Mut., 6, 593-594.
18. Posey, K.L., Yang, Y., Veerisetty, A.C., Sharan, S.K. and Hecht, J.T. (2008) Model systems for studying skeletal dysplasias caused by TSP-5/COMP mutations. Cell Mol. Life Sci., 65, 687-699.
19. Spitznagel, L., Nitsche, D.P., Paulsson, M., Maurer, P. and Zaucke, F. (2004) Characterization of a pseudoachondroplasia-associated mutation (His587.Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP). Biochem. J., 377, 479-487.
20. Pirog-Garcia, K.A., Meadows, R.S., Knowles, L., Heinegard, D., Thornton, D.J., Kadler, K.E., Boot-Handford, R.P. and Briggs, M.D. (2007) Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP. Hum. Mol. Genet., 16, 2072-2088.
21. Hecht, J.T., Deere, M., Putnam, E., Cole, W., Vertel, B., Chen, H. and Lawler, J. (1998) Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues. Matrix Biol., 17, 269-278.
22. Delot, E., King, L.M., Briggs, M.D., Wilcox, W.R. and Cohn, D.H. (1999) Trinucleotide expansion mutations in the cartilage oligomeric matrix protein (COMP) gene. Hum. Mol. Genet., 8, 123-128.
23. Weirich, C., Keene, D.R., kirsch, K., Heil, M., Neumann, E. and Dinser, R. (2007) Expression of PSACH-associated mutant COMP in tendon fibroblasts leads to increased apoptotic cell death irrespective of the secretory characteristics of mutant COMP. Matrix Biol., 26, 314-323.
24. Hecht, J.T., Montufar-Solis, D., Decker, G., Lawler, J., Daniels, K. and Duke, P. (1998) Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes. Matrix Biol., 17, 625-633.
25. Jakkula, E., Lohiniva, J., Capone, A., Bonafe, L., Marti, M., Schuster, V., Giedion, A., Eich, G., Boltshauser, E., Ala-Kokko, L. and Superti-Furga, A. (2003) A recurrent R718W mutation in COMP results in multiple epiphyseal dysplasia with mild myopathy: clinical and pathogenetic overlap with collagen IX mutations. J. Med. Genet., 40, 942-948.
26. Unger, S., Bonafe, L. and Superti-Furga, A. (2008) Multiple epiphyseal dysplasia: clinical and radiographic features, differential diagnosis and molecular basis. Best Pract. Res. Clin. Rheumatol., 22, 19-32.
27. Boennemann, C.G., Cox, G.F., Shapiro, F., Wu, J.J., Feener, C.A., Thompson, T.G., Anthony, D.C., Eyre, D.R., Darras, B.T. and Kunkel, L.M. (2000) A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. Proc. Natl Acad. Sci. USA, 97, 1212-1217.
28. Dubowitz, V., Sewry, C.A. and Lane, R.J.M. (2007) Muscle Biopsy: A Practical Approach, 3rd edn. Saunders Elsevier, Philadelphia.
29. Bodensteiner, J.B. (1994) Congenital myopathies. Muscle Nerve, 17, 131-144.
30. Ikezoe, K., Nakamori, M., Furuya, H., Arahata, H., Kanemoto, S., Kimura, T., Imaizumi, K., Takahashi, M.P., Sakoda, S., Fuji, N. et al. (2007) Endoplasmic reticulum stress in myotonic dystrophy type 1 muscle. Acta Neuropathol., 114, 527-535.
31. Volpe, P., Villa, A., Podini, P., Martini, A., Nori, A., Panzeri, M.C. and Meldolesi, J. (1992) The endoplasmic reticulum-sarcoplasmic reticulum connection: distribution of endoplasmic reticulum markers in the sarcoplasmic reticulum of skeletal muscle fibers. Proc. Natl Acad. Sci. USA, 89, 6142-6146.
32. Danielsson, O., Nilsson, C., Lindvall, B. and Ernerudh, J. (2009) Expression of apoptosis related proteins in normal and diseased muscle: A possible role for Bcl-2 in protection of striated muscle. Neuromuscul. Disord., 19, 412-417.
33. Basset, O., Boittin, F.X., Cognard, C., Constantin, B. and Ruegg, U.T. (2006) Bcl-2 overexpression prevents calcium overload and subsequent apoptosis in dystrophic myotubes. Biochem. J., 395, 267-276.
34. Svensson, L., Aszodi, A., Heinegard, D., Hunziker, E.B., Reinholt, F.P., Fassler, R. and Oldberg, A. (2002) Cartilage oligomeric matrix protein-deficient mice have normal skeletal development. Mol. Cell Biol., 22, 4366-4371.
35. Di Cesare, P.E., Hauser, N., Lehman, D., Pasumarti, S. and Paulsson, M. (1994) Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett., 354, 237-240.
36. Smith, R.K.W., Zunino, L., Webbon, P.M. and Heinegard, D. (1997) The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol., 16, 255-271.
37. Kjaer, M. (2004) Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol. Rev., 84, 649-698.
38. Tidball, J.G. (1991) Force transmission across muscle cell membranes. J. Biomech., 24, 43-52.
39. Garfin, S.R., Tipton, C.M., Mubarak, S.J., Woo, S.L., Hargens, A.R. and Akeson, W.H. (1981) Role of fascia in maintenance of muscle tension and pressure. J. App. Phys., 51, 317-320.
40. Wang, W.M., Banack, T.M., Tsai, C.W., Flatow, E.L. and Jepsen, K.J. (2006) Variability in tendon and knee joint biomechanics among inbred mouse strains. J. Orth. Res., 26, 1200-1207.
41. Viidik, A., Danielson, C.C. and Oxlund, H. (1982) On fundamental and phenomenological models, structure and mechanical properties of collagen, elastin and glycosaminoglycan complexes. Biorheology, 19, 437-451.
42. Kannus, P. (2000) Structure of the tendon connective tissue. Scand. J. Med. Sci. Sports, 10, 312-320.
43. Jozsa, J. and Kannus, P. (1997) Human Tendons: Anatomy, Physiology and Pathology. Human Kinetics, Champaign, IL, pp. 47-48, 54-55, 56-57, 59, 76-77, 80-81, 104.
44. Briggs, M.D. and Chapman, K.L. (2002) Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations. Hum. Mutat., 19, 465-478.
45. Posey, K.L. and Hecht, J.T. (2008) The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Curr. Drug Targets, 9, 869-877.
46. Bondestama, J., Pihkob, H., Vanhanenc, S.L., Branderc, A., Toiviainen-Salod, S., Marttinend, E. and Mäkitiea, O. (2007) Skeletal dysplasia presenting as a neuromuscular disorder-report of three children. Neuromuscul. Disord., 17, 231-234.
47. Riley, G.P. (2008) Tendinopathy-from basic science to treatment. Nat. Clin. Pract. Rheumatol., 4, 82-89.
48. Gustavson, K.H. and Jorulf, H. (1975) Different types of osteochondrodysplasia in a consecutive series of newborns. Helv. Paediatr. Acta, 30, 307-314.
49. Passerieux, E., Rossignol, R., Letellier, T. and Delage, J.P. (2007) Physical continuity of the perimysium from myofibers to tendons: involvement in lateral force transmission in skeletal muscle. J. Struct. Biol., 159, 19-28.
50. Mian, O.S., Thom, J.M., Ardigò, L.P., Minetti, A.E. and Narici, M.V. (2007) Gastrocnemius muscle-tendon behaviour during walking in young and older adults. Acta Physiol. (Oxf.), 189, 57-65.
51. Schmitz, M., Niehoff, A., Miosge, N., Smyth, N., Paulsson, M. and Zaucke, F. (2008) Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations. Matrix Biol., 27, 67-85.
52. Provenzano, P.P. and Vanderby, R. (2006) Collagen fibril morphology and organization: implications for force transmission in ligament and tendon. Matrix Biol., 25, 71-84.
53. Provenzano, P.P., Hurschler, C. and Vanderby, R. (2001) Microstructural morphology in the transition region between scar and intact residual segments of a healing rat medial collateral ligament. Connect. Tissue Res., 42, 123-133.
54. Yoon, J.H. and Halper, J. (2005) Tendon proteoglycans: biochemistry and function. J. Musculoskelet. Neuronal. Interact., 5, 22-34.
55. Benjamin, M. and Ralphs, J.R. (1996) Tendons in health and disease. Man. Ther., 1, 186-191.
56. Nakamura, N., Hart, D.A., Boorman, R.S., Kaneda, Y., Shrive, N.G., Marchuk, L.L., Shino, K., Ochi, T. and Frank, C.B. (2005) Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen fibrillogenesis in vivo. J.Orth. Res., 18, 517-523.
57. Ker, R. (2002) The implications of the adaptable fatigue quality of tendons for their construction, repair and function. Comp. Biochem. Physiol. A Mol. Integr. Physiol., 134, 987-1000.
58. Provenzano, P.P. and Vanderby, R. (2003) Collagen in connective tissue: form tendon to bone. J. Biomech., 36, 1523-1527.
59. Nigg, B.M., MacIntosh, B.R. and Mester, J. (2000) Biomechanics and Biology of Movement, illustrated edn. Human Kinetics Europe Ltd.
60. Savolainen, J., Väänänen, K., Puranen, J., Takala, T.E., Komulainen, J. and Vihko, V. (1988) Collagen synthesis and proteolytic activities in rat skeletal muscles: effect of cast-immobilization in the lengthened and shortened positions. Arch. Phys. Med. Rehabil., 69, 964-969.
61. Arampatzis, A., Karamanidis, K. and Albracht, K. (2007) Adaptational responses of the human Achilles tendon by modulation of the applied cyclic strain magnitude. J. Exp. Biol., 210, 2743-2753.
62. Woo, S.L., Ritter, M.A., Amiel, D., Sanders, T.M., Gomez, M.A., Kuei, S.C., Garfin, S.R. and Akeson, W.H. (1980) The biomechanical and biochemical properties of swine tendons-long term effects of exercise on the digital extensors. Connect. Tissue Res., 7, 177-183.
63. Ezura, Y., Chakravarti, S., Oldberg, A., Chervoneva, I. and Birk, D.E. (2000) Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J. Cell Biol., 151, 779-787.
64. Sodersten, F., Ekman, S., Niehoff, A., Zaucke, F., Heinegard, D. and Hultenby, K. (2007) Ultrastructural localisation of cartilage oligomeric matrix protein, thrombospondin-4, and collagen fibril size in rodent Achilles tendon in relation to exercise. Connect. Tissue Res., 48, 254-262.
65. Farndale, R.W., Buttle, D.J. and Barrett, A.J. (1986) Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylene blue. Biochim. Biophys. Acta, 883, 173-177.
66. Orioli, I.M., Castilla, E.E. and Barbosa-Neto, J.G. (1986) The birth prevalence rates for the skeletal dysplasias. J. Med. Genet., 23, 328-332.